Serum anti-p53 antibody as a tumour marker for colorectal cancer screening

ecancermedicalscience

Volumn 9, Issue , 2015, Pages

  Iwamuro, Masaya ^a,b   Kawai, Yoshinari ^b   Matsumoto, Tomoko ^b   Uda, Masashi ^b   Okada, Hiroyuki ^c  

^a OKAYAMA UNIVERSITY   (Japan)

^b Onomichi Municipal Hospital   (Japan)

^c OKAYAMA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Anti p53 antibody; Cancer screening tests; Colon cancers; Colorectal carcinoma; Early diagnosis of cancer

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; P53 ANTIBODY; PROTEIN ANTIBODY; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; ADVANCED CANCER; ANTIBODY BLOOD LEVEL; ARTICLE; ASCENDING COLON; CANCER SCREENING; CANCER SURGERY; CASE REPORT; COLON ADENOCARCINOMA; COLONOSCOPY; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC VALUE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERGLYCEMIA; HYPERLIPIDEMIA; JAPANESE (PEOPLE); LYMPH NODE DISSECTION; MALE; MIDDLE AGED; OCCULT BLOOD; PREOPERATIVE EVALUATION; TREATMENT OUTCOME;

EID: 84938686140     PISSN: None     EISSN: 17546605     Source Type: Journal    
DOI: 10.3332/ecancer.2015.560     Document Type: Article

References (20)

1. Takeda A et al (2001) Serum p53 antibody as a useful marker for monitoring of treatment of superficial colorectal adenocarcinoma after endoscopic resection Int J Clin Oncol 6(1) 45-9 DOI: 10.1007/PL00012079 PMID: 11706527
2. Baker SJ et al (1990) p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis Cancer Res 50(23) 7717-22 PMID: 2253215
3. Purdie CA et al (1991) p53 expression in colorectal tumors Am J Pathol 138(4) 807-13 PMID: 1707233 PMCID: 1886110
4. Soussi T (2000) p53 Antibodies in the sera of patients with various types of cancer: a review Cancer Res 60(7) 1777-88 PMID: 10766157
5. Suppiah A et al (2008) Anti-p53 autoantibody in colorectal cancer: prognostic significance in long-term follow-up Int J Colorectal Dis 23(6) 595-600 DOI: 10.1007/s00384-008-0458-4 PMID: 18330580
6. Kressner U et al (1999) Prognostic value of p53 genetic changes in colorectal cancer J Clin Oncol 17(2) 593-9 PMID: 10080604
7. Soong R et al (2000) Prognostic significance of TP53 gene mutation in 995 cases of colorectal carcinoma. Influence of tumour site, stage, adjuvant chemotherapy and type of mutation Eur J Cancer 36(16) 2053-60 DOI: 10.1016/S0959-8049(00)00285-9 PMID: 11044641
8. Staples OD, Steele RJ and Lain S (2008) p53 as a therapeutic target Surgeon 6(4) 240-3 DOI: 10.1016/S1479-666X(08)80034-0 PMID: 18697367
9. Finlay CA, Hinds PW and Levine AJ (1989) The p53 proto-oncogene can act as a suppressor of transformation Cell 57(7) 1083-93 DOI: 10.1016/0092-8674(89)90045-7 PMID: 2525423
10. Horn HF and Vousden KH (2007) Coping with stress: multiple ways to activate p53 Oncogene 26(9) 1306-16 DOI: 10.1038/sj.onc.1210263 PMID: 17322916
11. Crawford LV, Pim DC and Bulbrook RD (1982) Detection of antibodies against the cellular protein p53 in sera from patients with breast cancer Int J Cancer 30(4) 403-8 DOI: 10.1002/ijc.2910300404 PMID: 6292117
12. Pedersen JW et al (2013) Early detection of cancer in the general population: a blinded case-control study of p53 autoantibodies in colorectal cancer Br J Cancer 108(1) 107-14 DOI: 10.1038/bjc.2012.517 PMCID: 3553520
13. Muller M et al (2006) Testing for anti-p53 antibodies increases the diagnostic sensitivity of conventional tumor markers Int J Oncol 29(4) 973-80 PMID: 16964393
14. Lechpammer M et al (2004) Humoral immune response to p53 correlates with clinical course in colorectal cancer patients during adjuvant chemotherapy Int J Colorectal Dis 19(2) 114-20 DOI: 10.1007/s00384-003-0553-5
15. Polge A et al (1998) p53 and follow-up of colorectal adenocarcinomas Dig Dis Sci 43(7) 1434-42 DOI: 10.1023/A:1018890126260 PMID: 9690377
16. Angelopoulou K, Stratis M and Diamandis EP (1997) Humoral immune response against p53 protein in patients with colorectal carcinoma Int J Cancer 70(1) 46-51 PMID: 8985089
17. Hammel P et al (1997) Detection and monitoring of serum p53 antibodies in patients with colorectal cancer Gut 40(3) 356-61 DOI: 10.1136/gut.40.3.356 PMID: 9135525 PMCID: 1027086
18. Takeda A et al (2001) Monitoring of p53 autoantibodies after resection of colorectal cancer: relationship to operative curability Eur J Surg 167(1) 50-3 DOI: 10.1080/110241501750069828 PMID: 11213822
19. Zalcman G et al (1998) Monitoring of p53 autoantibodies in lung cancer during therapy: relationship to response to treatment Clin Cancer Res 4(6) 1359-66 PMID: 9626451
20. Lubin R et al (1995) Serum p53 antibodies as early markers of lung cancer Nat Med 1(7) 701-2 DOI: 10.1038/nm0795-701 PMID: 7585154